首页> 外文期刊>Health services research: HSR >Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
【24h】

Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.

机译:医疗保险的社会保障残疾保险人员在诊断和生存中处于癌症阶段。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To examine stage at diagnosis and survival for disabled Medicare beneficiaries diagnosed with cancer under age 65 and compare their experiences with those of other persons diagnosed under age 65. DATA SOURCES: Surveillance, Epidemiology, and End Results (SEER) Program data and SEER-Medicare linked data for 1988-1999. SEER-11 Program includes 11 population-based tumor registries collecting information on all incident cancers in catchment areas. Tumor registry and Medicare data are linked for persons enrolled in Medicare. STUDY DESIGN: 307,595 incident cases of non-small cell lung (51,963), colorectal (52,092), breast (142,281), and prostate (61,259) cancer diagnosed in persons under age 65 from 1988 to 1999. Persons who qualified for Social Security Disability Insurance and had Medicare (SSDI/Medicare) were identified from Medicare enrollment files. Ordinal polychotomous logistic regression and Cox proportional hazards regression were used to estimate adjusted associations between disability status and later-stage diagnoses and mortality (all-cause and cancer-specific). PRINCIPAL FINDINGS: Persons with SSDI/Medicare had lower rates of Stages III/IV diagnoses than others for lung (63.3 versus 69.5 percent) and prostate (25.5 versus 30.8 percent) cancers, but not for breast or colorectal cancers. After adjustment, they remained less likely to be diagnosed at later stages for lung and prostate cancers. Nevertheless, persons with SSDI/Medicare experienced higher all-cause mortality for each cancer. Cancer-specific mortality was higher among persons with SSDI/Medicare for breast and colorectal cancer patients. CONCLUSIONS: Disabled Medicare beneficiaries are diagnosed with cancer at similar or earlier stages than others. However, they experience higher rates of cancer-related mortality when diagnosed at the same stage of breast and colorectal cancer.
机译:目的:检查诊断为65岁以下癌症的残疾Medicare受益人在诊断和生存阶段,并将其与其他65岁以下诊断的人的经验进行比较。数据来源:监测,流行病学和最终结果(SEER)计划数据和SEER -Medicare 1988-1999年的链接数据。 SEER-11计划包括11个基于人群的肿瘤登记处,收集有关集水区所有发生的癌症的信息。参加Medicare的人员的肿瘤登记处和Medicare数据链接在一起。研究设计:1988年至1999年,在65岁以下人群中诊断出307,595例非小细胞肺癌(51,963),结直肠癌(52,092),乳腺癌(142,281)和前列腺癌(61,259)的发病病例。有社会保障残疾资格的人从Medicare注册文件中识别出保险和拥有Medicare(SSDI / Medicare)。有序多选择逻辑回归和Cox比例风险回归用于估计残疾状况与后期诊断和死亡率(全因和癌症特异性)之间的调整关联。主要发现:患有SSDI / Medicare的人在肺癌(分别为63.3%和69.5%)和前列腺癌(分别为25.5%和30.8%),而不是乳腺癌或结直肠癌中,III / IV期的诊断率比其他人低。调整后,他们在肺癌和前列腺癌的后期诊断中的可能性仍然较小。然而,患有SSDI / Medicare的人会因每种癌症而经历更高的全因死亡率。在患有SSDI / Medicare的乳腺癌和大肠癌患者中,癌症特异性死亡率更高。结论:残疾医疗保险受益人被诊断出与其他人相近或更早的癌症。但是,当在乳腺癌和大肠癌的同一阶段被诊断出时,他们经历与癌症相关的死亡率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号